This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Eureka Therapeutics, Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 621 
2 out of 52 Years Active: 2019-2026
Title: The Innovations of Inventor Andres Lopez-Albaitero
Introduction: Andres Lopez-Albaitero is a prominent inventor based in New York, NY, whose work has significantly impacted the field of cancer treatment. With six patents to his name, Lopez-Albaitero is known for his innovative approaches in developing bispecific binding molecules that target HER2 and CD3, two critical components in managing cancer therapies.
Latest Patents: His latest patents include compositions, methods, and uses involving bispecific HER2 and CD3 binding molecules. These molecules specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor. They mediate T cell cytotoxicity for managing and treating disorders such as cancer, particularly HER2-related cancers. Through these innovations, he aims to enhance the efficacy of treatments available for patients battling this devastating disease.
Career Highlights: Lopez-Albaitero has made notable contributions during his tenure at prestigious institutions such as Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. His work in these organizations has allowed him to advance his research and develop groundbreaking technologies that aim to combat cancer. His career reflects a dedication to improving patient outcomes through innovative scientific solutions.
Collaborations: Throughout his career, Lopez-Albaitero has collaborated with esteemed colleagues like Nai-Kong V Cheung and Hong Xu. These collaborations have fostered an environment of innovation and have contributed to the collective efforts in developing effective cancer therapies.
Conclusion: Andres Lopez-Albaitero's work exemplifies the spirit of innovation essential for progressing in medical science. His patents not only highlight his individual contributions but also represent a broader commitment to enhancing cancer treatment modalities. As he continues to forge ahead in his research, the impact of his inventions is likely to be felt across the medical field for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile